Cyclogyl 1 % Collirio Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

cyclogyl 1 % collirio

alcon switzerland sa - cyclopentolati hydrochloridum - collirio - cyclopentolati hydrochloridum 10 mg, acidum boricum, kalii chloridum, natrii carbonas monohydricus aut acidum hydrochloridum, dinatrii edetas, aqua purificata, benzalkonii chloridum 0.1 mg, ad solutionem pro 1 ml. - mydriatikum - synthetika

Mydrane soluzione iniettabile Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mydrane soluzione iniettabile

thea pharma s.a. - tropicamidum, lidocaini hydrochloridum monohydricum, phenylephrini hydrochloridum - soluzione iniettabile - tropicamidum 0.2 mg, lidocaini hydrochloridum monohydricum 10 mg, phenylephrini hydrochloridum 3.1 mg, dinatrii phosphas dihydricus, dinatrii phosphas dodecahydricus, natrii chloridum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 2.96 mg. - mydriatique - synthetika

Mydriasert insert ophtalmique Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mydriasert insert ophtalmique

thea pharma s.a. - phenylephrini hydrochloridum, tropicamidum - insert ophtalmique - phenylephrini hydrochloridum 5.4 mg, tropicamidum 0,28 mg, ammonio methacrylatis copolymerum a, acidi ethacrylici e methylis methacrylatis polymerisatum, glyceroli dibehenas, ethylcellulosum, per compresso haze. - mydriatique - synthetika

Fingolimod-Mepha Teva 0.5 mg Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

fingolimod-mepha teva 0.5 mg capsule

mepha pharma ag - fingolimodum - capsule - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, amylum pregelificatum, natrii laurilsulfas corresp. natrium 0.045 mg, kapselhülle: e 171, e 172 (flavum), gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Fingolimod Viatris 0,5 mg Capsule rigide Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

fingolimod viatris 0,5 mg capsule rigide

viatris pharma gmbh - fingolimodum - capsule rigide - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, calcii hydrogenophosphas dihydricus, glycinum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Gilenya 0.5 mg Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

gilenya 0.5 mg capsule

novartis pharma schweiz ag - fingolimodum - capsule - fingolimodum 0,5 mg per fingolimodi hydrochloridum, mannitolum, magnesio stearas, kapselhülle: e 172 (giallo), e 171, gelatina, drucktinte: lacca, alcol isopropylicus, alcol butylicus, propylenglycolum, acqua purificata, ammoniae soluzione del 28 per cento, kalii hydroxidum, e 172 (nero), e 172 (giallo), e 171, dimeticonum per una piccola scatola. - multiple sklerose - synthetika

Gilenya 0.25 mg Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

gilenya 0.25 mg capsule

novartis pharma schweiz ag - fingolimodum - capsule - fingolimodum 0.25 mg ut fingolimodi hydrochloridum, mannitolum, hydroxypropylcellulosum, hydroxypropylbetadexum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum pro capsula. - multiple sklerose - synthetika

Fingolimod-Mepha 0,25 mg Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

fingolimod-mepha 0,25 mg capsule

mepha pharma ag - fingolimodum - capsule - fingolimodum 0.25 mg ut fingolimodi hydrochloridum, amylum pregelificatum, natrii laurilsulfas corresp. natrium < 23 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum pro capsula. - multiple sklerose - synthetika

Fingolimod-Mepha 0,5 mg Capsule Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

fingolimod-mepha 0,5 mg capsule

mepha pharma ag - fingolimodum - capsule - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, amylum pregelificatum, natrii laurilsulfas corresp. natrium < 23 mg, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum pro capsula. - multiple sklerose - synthetika

Mictonorm 45 mg Gélules à libération modifiée Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mictonorm 45 mg gélules à libération modifiée

labatec pharma sa - propiverinum - gélules à libération modifiée - propiverini hydrochloridum 45 mg corresp. propiverinum 40.92 mg, acidum citricum, povidonum, lactosum monohydricum 8.5 mg, talcum, triethylis citras, magnesii stearas, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, matériel de la capsule: gelatina, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - incontinence, fréquence urinaire et urgence urinaire - synthetika